Evaluating Biomarkers at Work in NSCLC

Evaluating Biomarkers at Work in NSCLC

ReachMD Healthcare Image
RestartResume

What are some of the challenges that come with using biomarkers to treat non-small cell lung cancer?

  • Overview

    What do we need to know about the role of biomarkers in non-small cell lung cancer? Dr. Mark Awad from the Dana-Farber Cancer Institute explains.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free